MOTHER Labs, a Subsidiary of Medirom, Gains MLIT Certification for Fatigue Prevention Device

Reuters
Aug 29
MOTHER Labs, a Subsidiary of Medirom, Gains MLIT Certification for Fatigue Prevention Device

MEDIROM Healthcare Technologies Inc.'s subsidiary, MEDIROM MOTHER Labs Inc., has developed the "REMONY for Driver" system, which has been certified by Japan's Ministry of Land, Infrastructure, Transport and Tourism (MLIT) for its role in preventing fatigue-related driving. The system, which incorporates the MOTHER Bracelet, enables continuous health monitoring and sleep assessment of drivers. This innovation is aimed at enhancing safety standards in the transportation industry by reducing fatigue-related accidents, supported by a subsidy that covers 50% of the equipment acquisition cost. MOTHER Labs plans to further promote safe driving practices and strengthen fatigue prevention measures, contributing to a safer operational environment for transportation operators.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-011808), on August 28, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10